Fol. Biol. 2012, 58, 203-208
Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population
Individual author index pages
- Jaroslav A. Hubáček
- V. Staněk
- M. Gebauerová
- R. Poledne
- M. Aschermann
- H. Skalická
- J. Matoušková
- A. Kruger
- M. Pěnička
- H. Hrabáková
- J. Veselka
- P. Hájek
- V. Lánská
- V. Adámková
- J. Piťha
Other articles of these authors
-
Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery
Petr Kačer, J. Pirk, V. Lánská, J. A. Hubáček, V. Adámek, T. Červinková, J. Bělohoubek, O. Auzký, V. Adámková
2020, Vol. 66, Issue 4, pp. 148-153 -
Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes
Michal Vrablík, J. A. Hubáček, D. Dlouha, M. Satny, V. Adámková, R. Ceska
2019, Vol. 65, Issue 4, pp. 188-194 -
Cystatin C Is Associated with the Extent and Characteristics of Coronary Atherosclerosis in Patients with Preserved Renal Function
Aleš Král, T. Kovárník, Z. Vaníčková, H. Skalická, J. Horák, K. Bayerová, Z. Chen, A. Wahle, L. Zhang, K. Kopřiva, H. Benáková, M. Sonka, A. Linhart
2016, Vol. 62, Issue 6, pp. 225-234 -
Can Leukocyte Telomere Length Predict Survival Time in Heart Transplant Recipients over a Minimal Follow-Up of 20 years?
Dana Dlouhá, V. Vančura, J. Vymětalová, J. A. Hubáček, V. Lánská, I. Málek
2016, Vol. 62, Issue 5, pp. 188-193 -
CD14 Polymorphism Is Not Associated with SARS-CoV-2 Infection in Central European Population
Jaroslav A. Hubáček, Tom Philipp, Ondřej Májek, Dana Dlouhá, Věra Adámková, Ladislav Dušek
2023, Vol. 69, Issue 5-6, pp. 181-185 -
Nobody Is Perfect: Comparison of the Accuracy of PCR-RFLP and KASP™ Method for Genotyping. ADH1B and FTO Polymorphisms as Examples
Jaroslav A. Hubáček, H. Pikhart, A. Peasey, R. Kubínová, M. Bobák
2015, Vol. 61, Issue 4, pp. 156-160 -
Genetic Testing in the Management of Relatives of Patients with Hypertrophic Cardiomyopathy
Pavol Tomašov, M. Minárik, D. Zemánek, P. Čadová, S. Homolová, K. Čurila, M. Pěnička, L. Benešová, B. Belšánová, P. Gregor, J. Veselka
2014, Vol. 60, Issue 1, pp. 28-34 -
Tagging rs10811661 Variant at CDKN2A/2B Locus Is Not Associated with Type 2 Diabetes Mellitus in Czech Population
Jaroslav A. Hubáček, T. Neškudla, M. Klementová, V. Adámková, T. Pelikánová
2013, Vol. 59, Issue 4, pp. 168-171 -
Genetic Variants in Haem Oxygenase-1 and Endothelial Nitric Oxide Synthase Influence the Extent and Evolution of Coronary Artery Atherosclerosis
Aleš Král, T. Kovárník, L. Králík, H. Skalická, J. Horák, G. S. Mintz, J. Uhrová, M. Sonka, A. Wahle, R. Downe, M. Aschermann, P. Martásek, A. Linhart
2011, Vol. 57, Issue 5, pp. 182-190 -
INSIG2 G-102A Promoter Variant Exhibits Context-Dependent Effect on HDL-Cholesterol Levels but Not on BMI in Caucasians
Jaroslav A. Hubáček, P. Suchánek, V. Lánská, J. Piťha, V. Adámková
2011, Vol. 57, Issue 4, pp. 170-172 -
Why We Are Not Able to Find the Coronary Heart Disease Gene – apoE As an Example
Rudolf Poledne, J. A. Hubáček, V. Staněk, M. Aschermann, J. Matoušková, J. Veselka, P. Widimský, R. Cífková, V. Lánská, J. Piťha
2010, Vol. 56, Issue 5, pp. 218-222 -
INSIG2 Promoter Variant, Obesity Markers and Lipid Parameters – No Association in a Large Slavonic Caucasian Population Sample
Jaroslav A. Hubáček, L. Kuthanová, R. Bohuslavová, V. Adámková, V. Lánská, T. Meitinger, A. Pfeufer
2010, Vol. 56, Issue 3, pp. 131-134 -
Apolipoprotein E Arg136 → Cys in Individuals with Premature Myocardial Infarction
Jaroslav A. Hubáček, R. Poledne, J. Piťha, M. Aschermann, H. Skalická, V. Staněk
2009, Vol. 55, Issue 3, pp. 116-118